1. Glucokinase and hexokinase activities have been determined in the livers of newbom rats and attempts made to influence in vivo the development of the glucokinase. 2. Glucokinase first appears in rat liver about 16 days after birth and adult activities are reached 10-12 days later. Evidence is presented which indicates that this represents synthesis of new protein. Hexokinase activities remain constant throughout the period of glucokinase development. 3. Both exogenous glucose and insulin are necessary for the natural development of glucokinase, for this is retarded in starved and alloxan-diabetic neonatal rats. 4. The absence of glucokinase during the first 2 weeks of extrauterine life in the rat is not due to lack of insulin. 5. Attempts to advance the time at which glucokinase first appears by infusions of glucose, insulin and chlorpropamide alone and in various combinations have resulted in marginal effects only. 6. When rats are starved for 3 days during the period of glucokinase development and then re-fed, glucokinase is more rapidly synthesized, indicating that the potential ability to synthesize glucokinase continues to develop throughout the period of starvation. 7. Some possible reasons for the comparatively late development of glucokinase are discussed.
The first report (Walker, 1962) that adult liver contains two enzymes capable of catalysing the phosphorylation of glucose by ATP depended on a comparison of the effects of glucose concentration on the rate of phosphorylation of glucose by dialysed preparations of the supernatant fractions of homogenates of adult and foetal liver. Whereas foetal liver appears to contain only a single hexokinase (EC 2.7.1.1) having a low Km value for glucose, adult liver contains both the hexokinase and an enzyme having a high Km (about 10mm) that has been designated glucokinase (EC 2.7.1.2). These observations have subsequently been extended and confirmed (e.g. DiPietro, Sharma & Weinhouse, 1962; Walker, 1963b ; Viniuela, , and the adaptive nature of the glucokinase has been demonstrated (Salas, Vifiuela & Sols, 1963; Sharma, Manjeshwar & Weinhouse, 1963; Walker & Rao, 1964) . It is changes in the glucokinase activity that account for changes in the total glucose-phosphorylating capacity of the liver (e.g. DiPietro & Weinhouse, 1960; Niemeyer, Clark-Turri & Rabajille, 1963; Blumenthal, Abraham & Chaikoff, 1964; Borrebaek, Abraham & Chaikoff, 1964) .
The glucokinase must first appear at some stage during the growth of the animal. Preliminary observations with dialysed liver-supernatant preparations indicated that glucokinase develops immediately after birth in the guinea pig, whereas in the rat the enzyme is not detectable until some days after birth (Walker, 1963b) . The present paper reports in detail on the progress of the development of glucokinase in the neonatal rat, and examines some of the factors responsible for the control of this development. Evidence is presented which suggests that glucokinase cannot be synthesized until a certain stage of maturation of the liver cell is reached. Brief accounts of some of these results have appeared (Walker, , 1965 .
MATERIALS AND METHODS
Animals. The rats were of the Wistar albino strain maintained as described by Walker & Rao (1964) . Very young animals were selected at random from a large breeding colony for the normal development study. Birth dates of all litters were carefully recorded after daily inspection. For the study of effects of various treatments on glucokinase development, litters of rats were selected having ten to 12 animals/litter. Any obviously weakling animals were rejected.
Special care was taken when starving neonatal rats owing to their being poikilothermic. Such animals were kept in small boxes close to a radiator so that the ambient temperature was about 280. The younger animals, which could not drink water from the normal bottles, were offered water by teat pipette three times daily.
The production of alloxan-diabetes in neonatal rats 845 proved extremely difficult owing to a wide range of tolerance to the drug. Use of the procedure employed for adult rats by Walker & Rao (1964) (total vol. 1.5ml.) containing (final concentrations): glycylglycine buffer (50mM), adjusted to pH7-5 with NaOH; MgCl2 (7-5mM); ATP (5mM); NADP+ (0-5mm); 0-2 international unit of glucose 6-phosphate dehydrogenase; 0-02ml. of liver-supernatant preparation (prepared at 10OOOOg for 60min. in an MSE Super-Speed 40 refrigerated centrifuge, 8x lOml. angle rotor); glucose (100mM or 0-5mM). The temperature used was 280 and NADPH production was recorded on a Beckman recorder coupled to a Beckman model DB spectrophotometer. Glucokinase is calculated from the difference in rates with 100mM-and 0.5mM-glucose, and hexokinase from the difference in rates with 0-5mM-glucose in the presence and absence of ATP (Walker & Rao, 1964; Salas et al. 1963) . Frequent checks were also made with no ATP but 100mM-glucose to ensure that none of the recorded activity was due to the presence of glucose dehydrogenase [fl-D-glucose-NAD(P) oxidoreductase, EC 1.1.1.47], which also has a high K. for glucose and will also reduce NADP+ (Metzger, Wilcox & Wick, 1964) , either in the rat-liver preparation or in the added glucose 6-phosphate dehydrogenase.
Two additional points about methods must be made at this stage. (a) Duplicate assays with crude supernatant preparations showed that the rates of NADPH production were reproducible to within + 0-002 extinction unit/min. However, when the glucokinase activity is low its measurement depends on the small difference of rates of NADPH production with 100mM-and 0-5mM-glucose and the percentage error of reproducibility is correspondingly greater.
Thus glucokinase activities lower than about 0-065bmole/ min./g. wet wt. of liver are subject to considerable error.
(b) NADPH formation is due to oxidation of the glucose 6-phosphate formed being oxidized in the presence of exogenous glucose 6-phosphate dehydrogenase and also endogenous 6-phosphogluconate dehydrogenase (EC 1.1.1. 44). Some workers (e.g. Blumenthal et al. 1964 ) express results as ,&moles of NADPH formed and others (e.g. Viniuela et al. Salas et al. 1963) divide this by a factor between 1-5 and 2 to correct for the NADPH production by the second dehydrogenase and then express results as ,umoles of glucose phosphorylated. We have preferred to continue to divide the rate of NADP+ reduction by 2 (DiPietro & Weinhouse, 1960; Sharma et al. 1963; Walker, 1963b; Walker & Rao, 1964) for reasons previously stated, because the activities of 6-phosphogluconate dehydrogenase do not change significantly during the period of development under study , and particularly because rates of glucose phosphorylation in vivo are unlikely in any event to reach those recorded in vitro with 100mM-glucose (Walker & Rao, 1964) . Rates of glucose phosphorylation are expressed per g. wet wt. of liver, per whole liver and per 100 g. body wt. Statistical significance of means and differences were calculated by a t test.
Blood glucose and gluco8e tolerance. Blood glucose was determined as described by Walker & Rao (1964) . Glucose tolerance was estimated in animals previously starved overnight by giving glucose intragastrically [1g./kg. body wt. as a 20% (w/v) solution in water] by stomach tubes (made of fine nylon tubing) and killing the animals at specified times later. Litters of young rats were used in a procedure essentially the same as that used for fructose tolerance in neonatal rabbits by Walker (1963a) .
RESULTS
Preliminary evidence about the post-natal appearance ofglucokinase in the rat was obtained with dialysed liver-supernatant preparations (Walker, 846 1965 DEVELOPMENT OF RAT HEPATIC GLUCOKINASE HOLLAND 1963b) . Dialysis invariably leads to at least soImle loss of glucokinase activity and it is clearly advantageous to use fresh supernatant preparations. The accuracy of the determination is then subject only to the limitations mentioned in the Materials and Methods section with particular reference to the comments on low glucokinase activities. Table 1 shows that glucokinase is first detectable in rat liver about 15 or 16 days after birth. The rate of appearance of the enzyme is slow at first but then increases, the maximum rate of increase occurring during the period 21-25 days, with adult activities being recorded from about 27 days of age onwards. The range of activities at any one age were considerable, as indicated by S.D. values. These biological variations were nearly as great between siblings as between animals from various litters. No differences were noted between the sexes with respect to the development of the glucokinase. There was no correlation between either the age at which hepatic glucokinase activity could be detected or the age at which half adult activities were attained and the body weight of the neonatal animal at that time.
Throughout the whole of this period and also during the first 2 weeks of post-natal life the hexokinase activity remains essentially constant. A group of six determinations of hexokinase activity in foetal livers from rats of gestational age 19-21 days have activities of 0-31-0-61 ,umole of glucose phosphorylated/min./g. of liver (cf. Burch et al. 1963) .
The slow development and the wide variation in glucokinase activities, especially when the variation is considered as a percentage of the mean, has imposed a severe restriction on the design of further experiments on factors affecting the development of the glucokinase. First, the most suitable control animals would be littermates. This limits any one experiment to a maximum of about ten animals including both experimental and control animals. Secondly, a period of 3 days appears to be the minimum time over which a treatment must be given to permit a significant natural increase in the glucokinase activities in the control animals against which the effect of treatment may be assessed.
Evidence that glucokinase development represents synthesis of new protein. The low rate of appearance of glucokinase suggests that synthesis of new protein is involved, for an enzymic activation process is unlikely to take 10-12 days to complete. Tests were performed designed to detect the presence of an activator in adult liver or an inhibitor in foetal and immediately post-natal liver that would affect the glucokinase activity of liver preparations measured in vitro. These included the mixing of liver-supernatant preparations made from animals of various stages of development, the mixing of homogenates similarly before preparing mixed supernatant samples and the effects of short periods of incubation of mixed preparations before assay. Hexokinase and glucokinase activities of mixed samples were always the calculated arithmetic sum of the activities of the component liversupernatant preparations within the limits of experimental error.
Agents known to inhibit synthesis of protein seriously retarded the natural development of glucokinase. Litters of rats were treated with an amino acid antimetabolite alone or together with the natural analogue ( Table 2) . Simultaneous treatment of animals with methionine overcame an inhibitory effect of ethionine, and phenylalanine prevented inhibition of glucokinase development by p-fluorophenylalanine. All animals remained with their mothers during the experimental period so that individual food intakes could not be measured. Food (both milk and solids) was present in the stomachs of all animals when killed and the liver wt./body wt. ratio remained normal. The Glucose tolerance and insulin activity in the newborn rat. The maintenance of normal glucokinase in the adult rat depends on adequate dietary carbohydrate and insulin Sharma et al. 1963; Walker & Rao, 1964; Blumenthal et al. 1964) . The stomach of the newborn rat left with its mother is never empty, so that dietary carbohydrate is never lacking from the time of the first feed of milk within a few hours of birth. Insulin is present in the fl-cells of the islets of Langerhans of rat pancrease from about the seventeenth day of gestation (Dixit, Lowe, Heggested & Lazarow, 1964) . Blood glucose concentrations in the neonatal rat (Dawkins, 1963) are essentially normal compared with adult animals, and the young rat cannot be considered as being diabetic from the point of view of 'fasting' blood glucose concentrations, glucosuria, ketonuria etc.
Oral glucose tolerance tests were performed on several litters of rats at ages both before and after the development of glucokinase. Animals up to 16 days old started with slightly higher blood glucose concentrations, probably because of the small amount of food remaining in the stomach at the end of the 16hr. period of starvation. Glucose tolerance in litters IL, 1G and 1I (Table 3) was abnormal, but in litters 1K and 1J the oral dose of lmg. of glucose/g. body wt. was very efficiently tolerated. This difference correlates with the development of hepatic glucokinase but could also be due to a lack of an insulinogenic response to the glucose in the younger litters of animals. Insulin (soluble) was injected intramuscularly into young i-ats 8-13 days old and the blood glucose concentrations were determined 4hr. later. The blood glucose concentration was lowered by insulin (doses of 1-2units/ 100g. bodywt.) fromthe controlvalue of 111 + 6mg./ I00ml. ofbloodto 41 + 3 (means +s.E.M.) (P < 0-01). Little extra effect was seen with larger amounts of insulin (4-lOunits). Chlorpropamide given intraperitoneally had little or no effect on the blood glucose concentration after 4hr., but given by stomach tube it caused a significant fall in the blood glucose concentration in both starved and fed animals (47+5 and 69 + lOmg./lOOml. of blood respectively; P < 0-01). Animals examined between 8 and 24hr. after the intraperitoneal injection of chlorpropamide had lower-than-normal blood glucose concentrations, suggesting that administration by this route resulted in a slower but longer-lasting effect. It is concluded that chlorpropamide exerted an insulinogenic response in the young rats. There is no reason to suppose that glucose could not also cause insulin release, although direct blood insulin assays have not been performed.
Attempts to advance the age at which glucokinase first appears. If endogenous insulin can be released by normal insulinogenic stimuli then there is no apparent reason why glucokinase does not appear earlier. Attempts to bring forward the age at which glucokinase develops by treating neonatal rats with glucose, which is both the substrate of glucokinase and also an insulinogenic agent, with the insulinogenic drug chlorpropamide and with exogenous insulin were essentially negative. Half of three litters ofrats were injected intraperitoneally with 2m-moles of glucose/lOOg. body wt. each day from the age of 8 days until they were killed at 14, 16 or 18 days. Glucose treatment raised the glucokinase activities slightly but the difference was only statistically significant at 14 days of age (controls, 0-05 + 0-02; glucose-treated, 0-13 + 0-01; P < 0-01). Glucose treatment of other animals commencing Walker & Rao (1964) .
The production of alloxan-diabetes in neonatal rats proved very difficult. The dose response was extremely varied and the number of animals that survived the treatment and became grossly glycosuric was only about 20% of those injected. Neonatal rats were starved for 3 days during the period when the rate of increase of glucokinase~4 Table 5 . Role of insulin in the development of hepatic glucokinase in the neonatal rat
The animals used originated from three litters. The normal values quoted were for two animals from each litter. Alloxandiabetes was induced at 17 days old by intraperitoneal injection, and insulin (2units/lOOmg. body wt. daily) was injected intramuscularly when animals were 21, 22 and 23 days old. All animals were killed when 24 days old for enzyme and blood glucose determinations; further details of these treatments and of the assay procedures are given in the text. Results are expressed as means ±S.E.B.
Body wt.
(g.) 53±3 39±2
47±4
Liver wt. activities during natural development proceeds at the maximum rate, i.e. in the age region 21-25 days. They were then re-fed with glucose by stomach tube and permitted access to normal diet, and killed 16hr. later. The glucokinase activities (Table 6 ) in these animals were normal. Thus, although normal glucokinase development proceeds comparatively slowly and starvation results in lowered glucokinase activity, a rapid return to what are normal values for the given age of animal is achieved during the comparatively brief re-feeding period.
Indirect evidence that this rapid recovery was due to net synthesis of protein came from experiments in which neonatal animals were starved for the same 3-day period and then re-fed in the presence of known inhibitors of protein synthesis. The recovery of glucokinase activity on re-feeding was inhibited by p-fluorophenylalanine and actinomycin D, and the inhibitory effect of the former was essentially prevented by simultaneous injections of phenylalanine (Table 6 ).
DISCUSSION
The high apparent Km value for glucose possessed by glucokinase provides an enzymic explanation for the dependence on glucose concentration of various aspects of glucose utilization by the liver. The development of the enzyme at a comparatively late stage of development of the animal represents one of the final steps of liver maturation and coincides with the time at which rats first consume solid foods (Murphy & Dunn, 1949 ; and our own observations). Until the enzyme has developed the immature animal lacks the means of homeostatic control that glucokinase is believed to provide.
The absence of glucokinase in foetal liver is probably physiologically unimportant. Control of the foetal blood glucose concentration can be maintained by the maternal liver, for glucose readily traverses the placenta (Widdas, 1961) . The newborn rat during the first 2 weeks of extrauterine life can exert considerable control of its own carbohydrate metabolism without possessing hepatic glucokinase. Marked hyperglyeaemia is not observed and the only known significant difference is a lowered tolerance to glucose (Table 3) . One implication is that hepatic glucokinase may be of limited importance in the normal utilization of glucose by the animal and exists primarily to act as an overflow mechanism, i.e. to phosphorylate glucose when the blood glucose concentration increases above normal and thence initiate net hepatic glucose utilization (glycogen formation and oxidation). As emphasized by Walker & Rao (1964) , the glucokinase activities measured in vitro with lOOmm-glucose as substrate are never likely to be achieved in vivo, so that at all normal blood glucose concentrations the actual glucokinase activities may be only 25-50% of the maximum possible. This suggested confined role of glucokinase is perhaps additional support for the physiological concept (see, e.g., Weber, 1963 , for enzymic substantiation of this) that, under conditions other than those of high blood glucose concentrations, the primary function of the liver is to make glucose rather than to utilize it (Pesch & Topper, 1963) . The formation of respiratory carbon dioxide from glucose in the liver is low (Majchrowicz & Quastel, 1963) , and fatty acids are a major energy source of the liver (Fritz, 1961) .
Assuming that it is an essential first step, a fact that has been questioned (Figueroa, Pfeifer & Niemeyer, 1962) , the phosphorylation of glucose by the liver in the absence of glucokinase presents some problems. The non-specific low-Km hexokinase is available in the liver before glucokinase development (Burch et al. 1963 ; this paper), but its activity is low compared with that in other animal tissues (Long, 1952; Sols, 1964) and it may be subject to inhibition by glucose 6-phosphate (Crane & Sols, 1955) . The finding of high hexokinase activities in carcinomas arising from non-parenchymal (e.g. bile duct) liver cells (Sharma, Manjeshwar & Weinhouse, 1964) suggested that hexokinase was not present in the parenchymal cells (Sols, Salas & Vifnuela, 1964) . However, the recent report (Sharma, Sharma, Donnelly, Morris &Weinhouse, 1965) DEVELOPMENT OF RAT HEPATIC GLUCOKINASE hexokinase activities in certain parenchymal-cell hepatomas supports the suggestion (Walker, 1963b; Walker & Rao, 1964 ) that hexokinase and glucokinase are both present in the parenchymal cell. Other evidence obtained in vitro Lea & Walker, 1965) implies that hexokinase can participate in glucose utilization by liver tissue from both foetal and neonatal rats under some conditions. The low rate of development of glucokinase, the steady hexokinase activities during this period of glucokinase development, the absence of any indication of enzymic activators or inhibitors and the effects of known inhibitors of protein synthesis all suggest, but do not prove, that the development of the enzyme represents an initiation ofand increasing ability to synthesize new protein. Dietary glucose and insulin are clearly necessary for normal development, but it is apparently not a lack of these agents that accounts for the absence of the enzyme before a certain stage of maturity. The suppression of glucokinase synthesis may be affected by physiological conditions existing in the neonatal animal the nature of which are at present unknown.
The most significant results (Table 6) indicate that, during a period of starvation imposed at a time when glucokinase activity would normally be increasing at a maximum rate, the potential ability to synthesize glucokinase increases even though the observed activity actually decreases. This increase reveals itself on re-feeding the starved animal, when a rapid increase in glucokinase activity ensues, and is prevented by p-fluorophenylalanine and actinomycin, as is the natural increase in activity during the normal period of development. Ethionine and p-fluorophenylalanine have been used previously to prevent glucokinase synthesis on re-feeding starved adult rats Sharma et al. 1963) . p-Fluorophenylalanine competes with its natural analogue in protein synthesis (Kit, Dubbs & Piekarski, 1962) at the stage of activation and attachment to transfer RNA (Arnstein & Richmond, 1964) . The inhibitory effect of actinomycin D (Table 10) , which inhibits protein synthesis by preventing the formation of messenger RNA (Reich, 1963) , implies that the rapid increase in glucokinase depends on the formation of messenger RNA.
The interpretation of experiments that employ inhibitors of protein synthesis as evidence that an increase in measurable enzymic activity represents new synthesis of protein always assumes that the rate of breakdown of the enzyme protein remains constant, i.e. dependent only on the steady-state concentration of the enzyme. Recent work on hepatic tryptophan pyrrolase (Schimke, Sweeney & Berlin, 1964) and arginase (Schimke, 1964) clearly indicates that such an assumption is not always valid and tha,$ in some mammalian metabolic adaptations, marked changes in the rate of enzyme degradation can take place. Although rates ofglucokinase breakdown have not been measured, it seems unlikely that the induction of enzyme synthesis, where the initial enzyme activity is virtually zero, could be due to a marked decrease in rate ofdegradation. Such a mechanism of enzyme induction would, in any case, be a biologically wasteful process.
An explanation is required as to how glucose and insulin affect glucokinase synthesis and the reason why they cannot exert their effect before a certain time. Considering the problem against the background of current models for the induction and regulation of protein synthesis (Jacob & Monod, 1961) , either transcription or translation or both sites of the process might be affected. The dependence of the control of glucokinase synthesis on messenger-RNA formation is implied by the inhibitory action of actinomycin D. If insulin itself is necessary for glucokinase synthesis, and all the evidence from studies in vivo suggests that it is (Sharma et al. 1963; Salas et al. 1963 ), then we must ask whether it acts directly or indirectly (Steiner & King, 1964) as an inducer. Some of the evidence for the role of insulin as a protein anabolic agent has been mentioned by Walker & Rao (1964) (for a recent review see Lukens, 1964) , and an effect of insulin on transcription is attractive in explaining how insulin can have a marked effect, not only on the synthesis of certain enzymes such as hepatic glucokinase and UDP-glucose-glycogen glucosyltransferase (EC 2.4.1.11) (Steiner & King, 1964) , but also in apparently repressing the stimulating effect of glucocorticosteroids on several of the key enzymes involved in hepatic gluconeogenesis (Weber, Singhal, Stamm, Fisher & Mentendiek, 1964) .
From studies on the effect of insulin on messenger-RNA synthesis in muscle tissue, Wool & Moyer (1964) proposed that an effect of insulin on transcription cannot explain all the observed facts and they have suggested that insulin may also have an effect at the ribosomal level. Walker (1965) collated some of the changes in the physical nature of the protein-synthetic apparatus of the cell that are known to occur during the post-natal development of the liver. In view of the dependence of protein synthesis on morphological structure (Campbell & Sargent, 1964; Villa-Trevino, Farber, Staehelin, Wettstein & Noll, 1964) 
